The NASS Podcast

Ask the Experts: A Lifelong Learning Series - October 2021

Mark Mikhael, MD

Disclosures:

Khachatryan, Armen: Speaking and/or Teaching Arrangements: Zimmer Biomet Spine (E); Trips/Travel: Zimmer Biomet Spine (B).

Mikhael, Mark M.: Consulting: Clariance Spine (B).

Reddy, Deepak: Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Members of the Section on Biologics & Basic Research, W. Mark Erwin, DC, PhD and Zorica Buser, PhD, MBA, discuss the term “DDD” and what accepted science defines as DDD as well as what the salient cellular, molecular and imaging characteristics are that define DDD as compared to normal ‘ageing’ changes. Additional questions addressed include: What characteristics and symptoms are shared and NOT shared with the ageing disc?   How does one delineate these distinctions clinically?  Is it possible?  How do the cellular/molecular changes associated with the degenerative disc correlate with a patient’s symptoms?  How much degeneration is ‘necessary’ before symptoms manifest?  Is this even known?

Ask the Experts: A Lifelong Learning Series - October 2021

Eric Nottmeier, MD

Disclosures:

Nottmeier, Eric W.: Royalties: Globus Medical (F, Paid directly to institution/employer), Symgery (B, Paid directly to institution/employer); Stock Ownership: Lessray (Future Compensation Expected), Mirus (Future Compensation Expected), Surgical Spotlight Inc (Future Compensation Expected), Trackx (Future Compensation Expected).

Pirris, Stephen: Other: MedCyclops (None); Stock Ownership: ORHub (100,000 Shares, 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Moderator Tobias Mattei, MD chats with author Max Hans-Peter Gay, PhD about his article titled, "Computed tomography osteoabsorptiometry for imaging of degenerative disc disease."

Access article here.

Disclosures:

Gay, Max Hans-Peter: Nothing to Disclose

Mattei, Tobias Alecio: Nothing to Disclose

Ask the Experts: A Lifelong Learning Series - October 2021

Disclosures:

Blumenthal, Scott L.: Consulting: Aesculap (C), Bayliss Medical (B), Degen Medical (C), NeoSpine (C), Orthofix (C); Device or Biologic Distribution Group (Physician-Owned Distributorship): Aesculap (A); Scientific Advisory Board: Aesculap (B), FzioMed (None); Speaking and/or Teaching Arrangements: Aesculap (D), Bayliss (None), NuVasive (None); Stock Ownership: Centinel Spine (1%), FzioMed (1%).

Guyer, Richard D.: Consulting: Aescalup (C), Orthofix (D), Spinal Kinetics (B); Royalties: ATEC (B), Nanovis (D), Stryker - K2M (B).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Moderator Tejas Shah, MD, chats with authors Kevin Davis, BS, and Iahn Cajigas, MD, PhD, about their article, "Brain-Computer Interfaces for Spinal Cord Injury - Technology Progressing Toward a Clinical Reality."  

Access the article here.

Disclosures:

Cajigas, Iahn: Grants: Boston Scientific (None); Stock Ownership: Kinesiometrics LLC (less than 1%).

Davis, Kevin: Nothing to Disclose

Shah, Tejas : Nothing to Disclose

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Ask the Experts: A Lifelong Learning Series - October 2021

Disclosures:

Goodwin, Matthew L.: Consulting: Augmedics (A, Outside 12-Month Requirement), JBJS Classroom (A); Fellowship Support: AOSpine (Salary), NREF (Salary); Royalties: Kendall Hunt (B); Stock Ownership: ROM3 (200 Shares, Outside 12-Month Requirement, Paid directly to institution/employer).

Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (Nonfinancial); Speaking and/or Teaching Arrangements: AOSpine (Travel Expense Reimbursement, Outside 24-Month Requirement).

Sciubba, Daniel M.: Consulting: Baxter (B), DePuy Synthes (B), Medtronic (D), Stryker (C).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Use of neuromonitoring during spinal cord stimulator surgery varies significantly across the US. In some regions, multimodality neuromonitoring is used routinely for all procedures. In other regions, it’s rarely used at all. With more than a decade of research on the utility of IONM for SCS placement, Dr. Falowski is interviewed by Dr. Vogel about the results of his research.

Richard Vogel, PhD, DABNM- Neurological Monitoring Associates, LLC, Milwaukee, WI

Stephen M. Falowski, MD- St. Lukes University Health Network, Bethlehem, PA

Disclosures:

Falowski, Steven M.: Consulting: Abbott (F), Medtronic (E), Vertiflex (F), Vertoss (D); Stock Ownership: AGR (less than 1%), Celeri (less than 1%), Cornerloc (less than 1%), Neural Integrative Solutions (50%), Saluda (less than 1%), Spinethera (less than 1%), SPR (less than 1%), Stimgenics (less than 1%), Thermaquil (less than 1%).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President (2019-2020)); Other: NuVasive Clinical Services (Salary, employment ended May 2021); Stock Ownership: NuVasive (less than 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Neuromonitoring is a widely accepted method for evaluating spinal cord and nerve root function in spinal deformity surgery; however, methods vary significantly in the US and around the world. In this episode, Dr. Simon Harris is interviewed for his perspective as an orthopedic spine surgeon who focuses on spinal deformity surgery in Toronto, Canada.

Disclosures:

Harris, Simon: Nothing to Disclose

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, Past President); Other: NuVasive Clinical Services (Salary).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Ask the Experts: A Lifelong Learning Series - October 2021

John H. Shin, MD

Disclosures:

Goodwin, C. Rory: Consulting: Medtronic (B); Grants: Federal Food And Drug Administration (G, Paid directly to institution/employer), NIH/NINDS (F, Paid directly to institution/employer), Robert Wood Johnson Foundation (F, Paid directly to institution/employer).

Patt, Joshua  C.: Board of Directors: AOA (Nonfinancial, Council of Orthopaedic Residency Directors Chair, Executive Committee Member).

Shin, John H.: Consulting: Carbofix (None), DePuy (B), Medtronic (A), NuVasive (B).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+